ישראל - עברית - Ministry of Health

csl behring ltd., israel - factor xiii - powder for solution for injection - factor xiii 200 - 320 iu - coagulation factor xiii - coagulation factor xiii - congenital or acquired factor xiii deficiency, or to promote healing of wounds and bone fractures. congenital deficiency of factor xiii and resultant haemorrhagic syndroms

ישראל - עברית - Ministry of Health

csl behring ltd., israel - factor xiii - powder for solution for injection - factor xiii 1250 iu - coagulation factor xiii - coagulation factor xiii - congenital or acquired factor xiii deficiency or to promote healing of wounds and bone fractures. congenital deficiency of factor xiii and resultant haemorrhagic syndroms

ישראל - עברית - Ministry of Health

gsk consumer healthcare, israel ltd - lidocaine hydrochloride; tribenoside - קרם - tribenoside 5 %; lidocaine hydrochloride 2.12 % - tribenoside - tribenoside - external & internal haemorrhoids

ישראל - עברית - Ministry of Health

gsk consumer healthcare, israel ltd - lidocaine; tribenoside - פתילות - tribenoside 400 mg; lidocaine 40 mg - tribenoside - tribenoside - local relief of haemorrhoids.

ישראל - עברית - Ministry of Health

csl behring ltd., israel - anti-d immunoglobulins - תמיסה להזרקה - anti-d immunoglobulins 150 mcg/ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - prophylaxis of rh (d) immunisation in rh (d)-negative women: anti-d immune globulin is administered for the prevention of rh (d) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. treatment is not necessary when it is assured that the child or the father are rh (d)- negative. criteria for a rhesus-incompatible pregnancy and the administration of anti-d immune globulin are : a) the mother is rh (d) -negative b) the child is either rh (d)-positive rh (d)weak - positive or its rhesus type is not known. routine antepartum prophylaxis : to prevent rh (d) immunisation due to spontaneous fetomaternal haemorrhage (fmh) during the last trimester of pregnancy. postpartum prophylaxis to prevent rh (d) immunisation of the rh (d)-negative mother following delivery of a rh (d)-positive child. complications of pregnancy: interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood s

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - diclofenac sodium 50 mg; misoprostol 0.2 mg - tablets - diclofenac, combinations - for patients requiring long term anti-inflammatory treatment, in such circumstances where there is a high risk of developing hemorrhaege or ulcer, i.e. patients with a peptic ulcer or past gastric bleeding, patients with cardiovascular disease, patients over 65 and smokers.

ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 125 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 500 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

novartis israel ltd - deferasirox - טבליות ניתנות לפיזור - deferasirox 250 mg - deferasirox - deferasirox - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over).exjade is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration (lic) >5 mg fe/g dry weight (dw) following mri and serum ferritin >800 nanogram/ml).

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - אבקה וממס להכנת תמיסה להזרקה\אינפוזיה - alteplase 50 mg/vial - enzymes - acute myocardial infarction in adults for the lysis of thrombi obstructing coronary arteries the improvement of ventricular function and reduction of the incidence of congestive heart failure. pulmonary embolism with hemodynamic deprivation. for fibrinolytic treatment of acute ischaemic stroke. treatment must be started within 3 hours of onset of the stroke symptoms and after prior exclusion of intracranial haemorrhage by means of appropriate imaging techniques.this treatment is restricted to a prescription by aspecialist in neurology.